MARCUZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 6.591
EU - Europa 4.047
AS - Asia 943
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 11
OC - Oceania 1
Totale 11.636
Nazione #
US - Stati Uniti d'America 6.578
PL - Polonia 2.427
SE - Svezia 483
CN - Cina 339
UA - Ucraina 308
IT - Italia 307
HK - Hong Kong 223
SG - Singapore 220
FI - Finlandia 113
DE - Germania 93
TR - Turchia 88
BG - Bulgaria 76
IE - Irlanda 71
FR - Francia 44
GB - Regno Unito 37
VN - Vietnam 37
BE - Belgio 27
SN - Senegal 26
CH - Svizzera 13
KR - Corea 13
CA - Canada 12
NL - Olanda 11
EU - Europa 9
IN - India 8
ES - Italia 7
RO - Romania 7
RU - Federazione Russa 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BR - Brasile 4
CL - Cile 3
DK - Danimarca 3
IL - Israele 3
NG - Nigeria 3
GR - Grecia 2
HR - Croazia 2
JP - Giappone 2
PT - Portogallo 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 11.636
Città #
Warsaw 2.425
Fairfield 899
Woodbridge 840
Houston 669
Ann Arbor 625
Chandler 506
Ashburn 503
Seattle 429
Wilmington 406
Jacksonville 298
Cambridge 294
Hong Kong 221
Singapore 168
Princeton 136
Trieste 108
Beijing 84
Dearborn 83
Sofia 76
Izmir 72
Dublin 71
Boardman 48
Dong Ket 36
San Diego 36
Falls Church 35
Dakar 26
Grafing 26
Brussels 25
Santa Clara 24
Helsinki 23
Jinan 23
Des Moines 21
Hefei 20
Phoenix 20
Kunming 18
Washington 18
Nanjing 17
Shanghai 17
Hebei 15
Redwood City 15
Dallas 11
Seoul 11
Bremen 10
Columbus 10
Milan 10
Chicago 9
Nanchang 9
Toronto 9
Fuzhou 8
Guangzhou 8
Kocaeli 8
Fremont 7
Shenyang 7
Bern 6
Changsha 6
Chengdu 6
Edinburgh 6
Los Angeles 6
Taizhou 6
Venezia 6
London 5
New York 5
Zhengzhou 5
Amsterdam 4
Andover 4
Ankara 4
Berlin 4
Bologna 4
Brescia 4
Haikou 4
Norwalk 4
Pune 4
Tappahannock 4
Tianjin 4
Brøndby 3
Buffalo 3
Centro 3
Chongqing 3
Detroit 3
Dongguan 3
Düsseldorf 3
Fort Worth 3
Gorizia 3
Lagos 3
Leawood 3
Mumbai 3
North Bergen 3
Nürnberg 3
Perugia 3
Rome 3
San Francisco 3
Silea 3
São Paulo 3
Taiyuan 3
Zurich 3
Anqing 2
Athens 2
Augusta 2
Caracas 2
Chaoyang 2
Edmonton 2
Totale 9.669
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 358
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 344
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 338
Alendronate, a double-edged sword acting in the mevalonate pathway 334
Neuronal Dysfunction Associated with Cholesterol Deregulation. 325
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 318
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 309
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 303
Two‑gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. 303
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 298
Type i interferon-mediated autoinflammation due to DNase II deficiency 293
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 274
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 264
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 244
Clinical Genetic Testing of Periodic Fever Syndromes 232
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 226
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 225
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. 187
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 186
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. 184
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). 181
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 179
A common genetic background could explain early-onset Crohn's disease. 176
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 175
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 175
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. 174
Inflammation profile of four early onset Crohn patients. 174
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 171
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. 169
Database tools in genetic diseases research. 167
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 163
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 159
Mevalonate kinase deficiency and IBD: shared genetic background 157
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 157
Cytokine levels in the serum of healthy subjects. 155
Evolutionary hypothesis of the Mevalonate Kinase Deficiency. 153
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 150
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 148
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 147
Serum amyloid A and cholesterol: a pivotal role on inflammation. 147
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 144
Putative modifier genes in mevalonate kinase deficiency 144
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 141
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 141
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 134
Family history in early-onset inflammatory bowel disease 131
null 130
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 130
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. 121
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 114
Presence of IL-9 in paired samples of human colostrum and transitional milk. 109
null 109
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 109
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 108
null 108
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 108
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. 97
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. 92
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 88
null 86
New Mechanisms in Autoinflammatory Diseases 86
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 85
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 81
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. 78
Role of vitamin D in the pathogenesis of atheromatosis 69
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 67
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 59
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 52
The effect of clodronate on a mevalonate kinase deficiency cellular model. 44
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 34
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis 32
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 31
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study. 26
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 24
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 13
Totale 11.947
Categoria #
all - tutte 26.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.720 0 0 178 490 216 432 376 290 270 152 199 117
2020/20211.820 173 150 150 186 185 185 166 127 118 190 67 123
2021/2022974 48 50 56 59 78 102 58 18 98 91 77 239
2022/20231.384 164 201 118 206 117 246 1 109 145 10 56 11
2023/2024805 33 57 56 54 81 99 160 148 14 9 56 38
2024/2025258 26 80 152 0 0 0 0 0 0 0 0 0
Totale 11.947